You are here: Home » News » Global Health
Category: Global Health
U.S. has a higher rate of babies born too early than more than 125 other countries, including Rwanda, Uzbekistan, China and Latvia, according a new report produced by 50 organizations, including the Global Alliance to Prevent Prematurity and Stillbirth (GAPPS), an initiative of Seattle Children’s.
Dr. Wecker, who has been Global Program Leader, Vaccine Access and Delivery at PATH, succeeds Dr. Jack Faris, who has been serving as acting CEO during the past eighteen months. Dr. Faris will remain part of the PNDRI team as a strategic advisor.
Dr. Corey is an expert in virology, immunology and vaccine development. His research has focused on herpes viruses, HIV and other viral infections, particularly those associated with cancer.
Davis will oversee PATH’s annual budget of $305 million, a staff of nearly 1,200, and a portfolio of projects based in PATH offices in 22 countries. He succeeds Dr. Christopher J. Elias, who left PATH to become president of the Global Development Program at the Bill & Melinda Gates Foundation.
The U.S. may soon start seeing a rising number of untreatable cases of gonorrhea unless new drugs can be found to combat emerging strains that are resistant to existing antibiotics, scientists warn in this week’s issue of The New England Journal of Medicine. “It is time to sound the alarm,” said the UW’s Dr. Judy Wasserheit, one of the authors of the journal article.
To mark World AIDS Day, the UW’s Dr. James Kublin, executive director of the HIV Vaccine Trials Network, would like to debunk the top 10 myths about HIV vaccine research.
Despite a recession, the number of jobs in Washington state’s life sciences sector rose 9 percent from 2007 through the first quarter of this year, according to a report released at the Washington Biotechnology & Biomedical Associations 2011 Governor’s Life Sciences Annual.
In his new positions, Dr. Christopher Elias will focus on developing integrated health-care delivery of interventions for the developing world.
A malaria vaccine developed by the pharmaceutical company GSK and Seattle’s PATH has been shown to halve the risk of severe malaria in African children.
Take one pill a day can more than halve the risk that an uninfected partner will contract HIV from an infected sexual partner, a University of Washington study has found.
Cancer’s impact on the developing world goes largely unrecognized and unaddressed, panelists said at a Seattle World Affairs Council event held Wednesday night at the Fred Hutchinson Cancer Research Center.
German health authorities have linked the E. coli outbreak that has killed 22 and sickened 1,700 people across Europe to locally grown bean sprouts, the European press is reporting today.
Recent Comments